Extracorporeal photopheresis in the treatment of persistent rejection in a pediatric lung transplant recipient

Barbara V. Wise, Karen E. King, Alain H. Rook, Peter J. Mogayzel

Research output: Contribution to journalArticle


Lung transplantation is an accepted therapy for children with end-stage lung disease. One-year lung transplant survival rates of 86% have been reported by the United Network for Organ Sharing. Allograft rejection is a common cause of death following transplantation. Extracorporeal photopheresis is a novel therapy used to treat solid-organ rejection; this therapy involves separating the leukocyte-rich fraction from whole blood, treating with psoralen and ultraviolet light A exposure. The objective of therapy is to reverse progressive and persistent rejection. Working collaboratively with an institution that offers extracorporeal photopheresis may provide an alternative or additional therapy in the management of ongoing rejection following solid-organ transplantation.

Original languageEnglish (US)
Pages (from-to)61-64
Number of pages4
JournalProgress in Transplantation
Issue number1
StatePublished - Mar 2003


ASJC Scopus subject areas

  • Transplantation

Cite this